We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




GE Healthcare Forms Strategic Relationship with Living Independently Group

By HospiMedica International staff writers
Posted on 22 Oct 2008
GE Healthcare (Chalfont St. More...
Giles, United Kingdom), a unit of General Electric (GE, Fairfield, CT, USA), has announced that it has entered into a distribution and technology collaboration agreement with the Living Independently Group (New York, NY, USA), a leading provider of telecare and passive monitoring systems used to assist in the care of senior citizens. Financial terms were not disclosed.

Under the terms of the agreement, GE Healthcare will distribute and co-market QuietCare, a behavioral remote patient monitoring system developed by Living Independently that uses wireless sensors to non-intrusively track the daily patterns of seniors' activities, discovering atypical activity patterns and behavioral changes that may signal potential health issues or emergency situations. The QuietCare system is used to alert caregivers to these changes in assisted living facilities, senior communities, and private homes. Additionally, as part of the agreement, the companies will utilize GE's Global Research Center and its advanced work in clinical parameters and monitoring algorithms to drive innovation in the field of remote patient monitoring and diagnostics. GE Healthcare will also take a minority ownership stake in Living Independently.

"Demographic changes such as the growing aging population present enormous healthcare challenges in the care of seniors and the management of chronic disease,” said Omar Ishrak, President and CEO of GE Healthcare's Clinical Systems business. "This is consistent with GE's strategy to invest in high growth businesses with global potential. We see enormous potential in senior healthcare monitoring, and the combined talent of the two companies offers the potential to accelerate the development of the business.”

"This is a very exciting development in the future of home healthcare,” said John L. Lakian, Chairman and CEO of Living Independently. "Leveraging the resources of GE Healthcare will allow us to significantly accelerate the evolution and capabilities of our QuietCare system and new applications for remote patient monitoring.”

Related Links:
GE Healthcare
General Electric
Living Independently Group


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Radiology System
Riviera SPV AT
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.